4//SEC Filing
Clifton R. LaDuane 4
Accession 0001437749-25-002625
CIK 0001434647other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 5:20 PM ET
Size
12.0 KB
Accession
0001437749-25-002625
Insider Transaction Report
Form 4
Clifton R. LaDuane
Other
Transactions
- Award
Restricted Stock Unit
2025-01-30+34,000→ 34,000 total→ Common Stock (34,000 underlying) - Exercise/Conversion
Common Stock
2025-01-31+43,333→ 62,361 total - Award
Stock Option (right to buy)
2025-01-30+68,000→ 68,000 totalExercise: $8.02Exp: 2035-01-29→ Common Stock (68,000 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-01-31−43,333→ 86,667 total→ Common Stock (43,333 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle inequal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date.
- [F3]Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.
- [F4]The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date.
Documents
Issuer
ZEVRA THERAPEUTICS, INC.
CIK 0001434647
Entity typeother
Related Parties
1- filerCIK 0001488774
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 5:20 PM ET
- Size
- 12.0 KB